How do I buy Revvity Inc. (RVTY) stock?

Buying Revvity Inc. (RVTY) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "RVTY", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy RVTY by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for RVTY on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Revvity Inc. from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Revvity Inc. (RVTY) pay dividends?

Yes, Revvity Inc. regularly pays dividends to shareholders. Currently, the estimated dividend yield for RVTY is around 0.18% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Is buying RVTY on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy RVTY?

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too. The market is closed on US public holidays. The Gotrade app shows whether the market is open.

How do I tell if RVTY is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Revvity Inc. (RVTY) Stock Price: Nov 11 Close $158.25

Latest news

Zacks Investment Research

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

PositiveRVTYOctober 27, 2026

Zacks Investment ResearchPositive

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

RVTY

Zacks Investment Research

ELV vs. RVTY: Which Stock Is the Better Value Option?

NeutralRVTYOctober 23, 2026

Zacks Investment ResearchNeutral

ELV vs. RVTY: Which Stock Is the Better Value Option?

RVTY

News tone: automated (AI) classification of the article's content, not a price prediction.

About Revvity Inc.

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

SectorHealthcare

IndustryDiagnostics & Research

Employees11,000

CEODr. Prahlad R. Singh Ph.D.

IPO DateApr 6, 1983

HeadquartersWaltham, MA

Key Executives

Name	Title	Year Born
Dr. Prahlad R. Singh Ph.D.	CEO, President & Director	1965
Mr. Maxwell Krakowiak	Senior VP & CFO	1990
Mr. Tajinder S. Vohra	Senior Vice President of Global Operations	1966
Mr. Joel S. Goldberg	Senior VP of Administration, General Counsel & Secretary	1969
Ms. Miriame Victor	Senior Vice President & Chief Business Officer	1981
Ms. Anita Gonzales	Chief Accounting Officer, VP & Controller	1976
Mr. Bryan A. Kipp	Senior VP of Technology & Licensing	—
Dr. Madhuri Hegde FACMG, Ph.D.	Senior VP & Chief Scientific Officer	—
Mr. Stephen Barr Willoughby	Senior VP of Investor Relations & Head of ESG	—
Ms. Magali Four	Senior VP and Chief People & Culture Officer	—

Fundamentals

Valuation

Price-to-sales ratio6.22

Price-to-book value2.46

PEG ratio0.73

Profitability

Return on Equity3.00%

Return on Assets2.00%

Return on Sales12.00%

Gross margin (latest quarter)57.43%

EBITDA$771.27M

Trading

Average volume1,872,455

Dividend

Ex dividend date23 Oct 2026

Last payment date7 Aug 2026

Source: third-party data provider, as of November 13, 2026

Technical indicators

RSI 14: 53.11
MACD 12/26/9: 2.37
EMA 9 of MACD: 3.18
MACD histogram: -0.81
SMA 50: $149.40; Price above SMA 50
EMA 50: $148.74; Price above EMA 50
SMA 200: $113.57; Price above SMA 200
EMA 200: $121.10; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst views

8 analyst ratings

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Hold

50% Buy

50% Hold

0% Sell

Analyst price target

Low: $140.00
Average: $168.14
High: $185.00

JP Morgan

Casey Woodring

Hold

Target price

$160.00

Barclays

Luke Sergott

Hold

Target price

$175.00

TD Cowen

Dan Brennan

Buy

Target price

$185.00

RBC Capital

Dan Leonard

Hold

Target price

$172.00

UBS

Doug Schenkel

Hold

Target price

$140.00

Evercore ISI Group

Vijay Kumar

Buy

Target price

$180.00

Keybanc

Paul Knight

Buy

Target price

$165.00

William Blair

Matt Larew

Buy

Target price

-

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-0.7	+8.6
2022	-10.4	+3.1	-1.5	-14.5	+1.2	-2.7	+6.3	-16.0	-11.1	+7.3	+2.3	-1.1
2023	-2.6	-10.6	+7.9	-0.7	-11.5	+2.7	+4.4	-4.6	-5.3	-23.2	+7.7	+19.8
2024	-2.9	+0.3	-2.0	-0.8	+6.5	-3.6	+22.0	-2.0	+6.7	-4.7	-4.0	-4.4
2025	+12.6	-9.3	-4.2	-10.4	-2.7	+8.3	-11.2	+2.1	-0.3	+2.0	+12.3	-5.5
2026	+10.9	-8.2	-8.3	-1.5	+20.6	+10.7	-0.3	+11.7	+20.8	+5.3	+4.4

Corporate actions

Upcoming

DividendQ1/27

Ex-dividend date22 Jan 2027

Payable date12 Feb 2027

Amount per share$0.07

DividendQ4/26

Ex-dividend date23 Oct 2026

Payable date13 Nov 2026

Amount per share$0.07

Past

DividendQ3/26

Ex-dividend date17 Jul 2026

Payable date7 Aug 2026

Amount per share$0.07

DividendQ2/26

Ex-dividend date17 Apr 2026

Payable date8 May 2026

Amount per share$0.07

DividendQ1/26

Ex-dividend date16 Jan 2026

Payable date6 Feb 2026

Amount per share$0.07

DividendQ4/25

Ex-dividend date17 Oct 2025

Payable date7 Nov 2025

Amount per share$0.07

DividendQ3/25

Ex-dividend date18 Jul 2025

Payable date8 Aug 2025

Amount per share$0.07

DividendQ2/25

Ex-dividend date17 Apr 2025

Payable date9 May 2025

Amount per share$0.07

DividendQ1/25

Ex-dividend date17 Jan 2025

Payable date7 Feb 2025

Amount per share$0.07

DividendQ4/24

Ex-dividend date18 Oct 2024

Payable date8 Nov 2024

Amount per share$0.07

DividendQ3/24

Ex-dividend date19 Jul 2024

Payable date9 Aug 2024

Amount per share$0.07

DividendQ2/24

Ex-dividend date18 Apr 2024

Payable date10 May 2024

Amount per share$0.07

DividendQ1/24

Ex-dividend date18 Jan 2024

Payable date9 Feb 2024

Amount per share$0.07

DividendQ4/23

Ex-dividend date19 Oct 2023

Payable date10 Nov 2023

Amount per share$0.07

DividendQ3/23

Ex-dividend date20 Jul 2023

Payable date11 Aug 2023

Amount per share$0.07

Compare stocks

RVTY

Buy RVTY

Market cap

$17.67B

-

Price / Earnings ratio

74.70

-

Price / Sales ratio

6.22

-

Dividend yield

0.18%

-

Average volume

1,872,455

-

Earnings per share

$2.09

-

Revvity Inc. (RVTY) Stock

Key stats

Compare with RVTY

Recent news

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Revvity (RVTY) Tops Q3 Earnings and Revenue Estimates

Revvity (RVTY) Tops Q3 Earnings and Revenue Estimates

Revvity Announces Financial Results for the Third Quarter of 2026

Revvity Announces Financial Results for the Third Quarter of 2026

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Revvity (RVTY) Tops Q3 Earnings and Revenue Estimates

Revvity (RVTY) Tops Q3 Earnings and Revenue Estimates

Revvity Announces Financial Results for the Third Quarter of 2026

Revvity Announces Financial Results for the Third Quarter of 2026

Revvity Board Declares Quarterly Dividend

Revvity Board Declares Quarterly Dividend

Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?

Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?

GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth

GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ELV vs. RVTY: Which Stock Is the Better Value Option?

ELV vs. RVTY: Which Stock Is the Better Value Option?

About Revvity Inc.

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade